London at IQVIA

Athens, Greece

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Pharmaceutical, Healthcare, Biotech, Medical DevicesIndustries

Requirements

Background in medical writing, particularly for HEOR (Health Economics and Outcomes Research) purposes
Experience with writing tasks in HEOR projects, including EU Joint Clinical Assessment (JCA) dossiers, HTA dossiers (e.g., NICE, SMC, NCPE), global value dossiers, protocols and reports for literature reviews, evidence synthesis, health economic modelling studies, peer-review manuscripts, and conference abstracts
Good understanding of matrix structures in the pharmaceutical industry and ability to navigate them to achieve client aims
Proven success in communicating scientific information strategically to optimize product access to markets and reimbursement
Qualifications and skills from disciplines such as health economics, statistics, biochemistry, or epidemiology (implied from team composition)

Responsibilities

Support the EMEA Health Economics team as a Consultant Medical Writer within the HTA Evidence & Strategy Centre of Excellence and Value Communications Centre of Excellence
Perform medical writing tasks within HEOR projects
Co-manage small workstreams, project tasks, and thought leadership initiatives with a senior team
Work in cross-functional and cross-country project teams, providing medical writing support
Undertake quality control on project deliverables
Contribute to the management of project delivery, including guiding the work of more junior team members
Support business development opportunities by exposure to EMEA RWS offerings in value communications, HTA strategy, and HEOR

Skills

Medical Writing

Value Dossier

Health Economics

Real World Evidence

Epidemiology

Statistics

Life Sciences

IQVIA

Advanced analytics and clinical research services

About IQVIA

IQVIA provides advanced analytics, technology solutions, and clinical research services specifically for the life sciences industry. Their services utilize extensive data resources and technology to create connections within healthcare, allowing clients to gain insights that help speed up the development and marketing of new medical treatments. This process is facilitated by their IQVIA Connected Intelligence™ system, which offers quick and flexible insights. IQVIA stands out from competitors by focusing on patient privacy, employing various technologies to protect individual data. The company's goal is to enhance healthcare outcomes by supporting biotech, pharmaceutical, and medical device companies, as well as researchers and government agencies, in understanding diseases and advancing medical science.

Durham, North CarolinaHeadquarters

1998Year Founded

$3,526MTotal Funding

POST_IPO_EQUITYCompany Stage

Cybersecurity, Biotechnology, HealthcareIndustries

10,001+Employees

Risks

Rapid advancement of cancer vaccines may disrupt traditional clinical research models.

Proliferation of disparate technological solutions causes technology overload in clinical trials.

Generative AI technologies face challenges in adoption due to data privacy concerns.

Differentiation

IQVIA leverages advanced analytics and big data for life sciences solutions.

The company offers privacy-enhancing technologies to protect individual patient data.

IQVIA's AI Assistant provides rapid, actionable insights for healthcare and life sciences.

Upsides

Increased adoption of decentralized clinical trials enhances patient-centric study designs.

AI-driven drug discovery accelerates identification of potential drug candidates.

Expansion of telemedicine facilitates remote patient monitoring and data collection.

Land your dream remote job 3x faster with AI

Try Jobo Free